QUCY — Quantum Cyber N.V.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1874252 ·
Germany
Last close
$1.14
Market Cap
$25.95M
52W High
$4.93
52W Low
$0.30
ADV30
3,275,527
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,463,043 | -5,081,982 | 7,717,957 | 4,450,193 | 3,128,665 |
| Dec 2025 | — | — | — | — | 5,327,396 | 889,091 | 4,685,796 |
| Jun 2025 | — | — | — | — | 9,803,514 | 1,911,069 | 7,281,165 |
| Mar 2025 | 0 | — | -2,745,525 | -5,002,891 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,224,148
Investing CF
$-1,101,781
Financing CF
$9,942,683
CapEx
$-1,101,781
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.89
As of
2026-05-21
Balance + Analyst (yfinance extras)
Retained Earnings
$-109,984,357
Inventory
$216,888
Receivables
$0
ST Investments
—
EBIT TTM
$-10,599,371
Pretax Income TTM
$-10,829,806
Interest Exp TTM
$230,435
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$537,080
EBITDA
$-12,703,465
Free Cash Flow
$-8,768,347
Enterprise Value
$12,425,935
Total Cash
$4,450,193
Total Debt
$126,791
Shares Out
22,767,254
Trailing EPS
$-2.10
Book Value
$0.36
ROE
-300.9%
ROA
-94.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 537,080 | -12,965,315 | -16,210,718 | 5,327,396 | 4,685,796 | — | -10,979,587 |
| Dec 2024 | 893,991 | -18,449,957 | -21,598,772 | 13,501,524 | 7,503,679 | — | -17,329,254 |
| Dec 2023 | 895,479 | -26,644,682 | -26,295,727 | 15,409,028 | 12,159,802 | — | -21,938,845 |
| Dec 2022 | 529,877 | -26,444,040 | -26,387,336 | 20,241,003 | 6,144,936 | — | -14,769,590 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IGC | IGC Pharma, Inc. | $26.09M | $0.25 | — |
| ABVC | ABVC BIOPHARMA, INC. | $26.26M | $1.01 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | $26.26M | $0.84 | — |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | $26.48M | $0.06 | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | $26.56M | $1.11 | — |
News headlines (Yahoo Finance, 1h cache)
Quantum Cyber Applauds President Trump's Drone Dominance Program and Supply Chain Framework, Reaffirms Commitment to On-Shore U.S. Manufacturing of Autonomous Systems
2026-07-29 11:30 · Yahoo
Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut
2026-07-27 11:30 · Yahoo
Quantum Cyber Completes Acquisition of U.S.-Based Manufacturing Facility in Bridgeport, Connecticut
2026-07-16 20:05 · Yahoo
Quantum Cyber shares rise after subsidiary secures $2.1 million in new orders (QUCY)
2026-07-16 12:44 · Yahoo
Quantum Cyber Reports Approximately $2 Million of Purchase Orders for Quantum Drone Corporation
2026-07-16 11:30 · Yahoo
Quantum Cyber Files for Drone Launch System Designed to Field Attritable Autonomous Drones at Scale
2026-07-14 13:07 · Yahoo
Quantum Cyber Addresses Short Seller Biased Report
2026-07-09 19:41 · Yahoo
Quantum Cyber Completes Confidential Submission to U.S. Army Program
2026-07-08 11:30 · Yahoo
Quantum Cyber Sets 100,000-Drone Annual Production Goal for Planned Connecticut Facility (QUCY)
2026-07-06 13:16 · Yahoo
Quantum Cyber Targets Annual Production Capacity of 100,000 Drones combining Kamikaze, Interceptor, Surveillance, VTOL and long-range Phantom 950 at Planned Bridgeport, Connecticut Manufacturing Facil
2026-07-06 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.